Renal Cancers Withdrawn Phase 2 Trials for Talabostat (DB06182)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00489710Talabostat in Treating Patients With Metastatic Kidney CancerTreatment